Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Macroeconomic Indicators
4.5 Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Opportunities
5.4 Pricing Analysis
Chapter 6. Global Soft Tissue Repair Market, by Product
6.1 Introduction
6.2 Fixation Products
6.2.1 Suture
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.2.2 Suture Anchors
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.2.3 Interference Screw
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.3 Tissue Patch/Match
6.3.1 Biological
6.3.1.1 Allograft
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.3.1.2 Xenograft
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.3.2 Synthetic
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.4 Laparoscopic Instrument
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.5 Others
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
Chapter 7. Global Soft Tissue Repair Market, by Application
7.1 Introduction
7.2 Orthopedic Surgery
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.3 Skin Repair
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.4 Hernia Repair
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.5 Vaginal Sling Repair
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.6 Dental Reconstruction
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.7 Cardiovascular Surgery
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.8 Breast Reconstruction
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.9 Others
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
Chapter 8. Global Soft Tissue Repair Market, by End User
8.1 Introduction
8.2 Hospitals
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
8.3 Clinics
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
8.4 Research & Academic Institutes
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
8.5 Others
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
Chapter 9. Global Soft Tissue Repair Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Stryker Corporation
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 C.R. Bard, Inc.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Arthrex, Inc.
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Integra LifeScience Corporation
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Depuy Synthes
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Smith & Nephew Plc
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Allergan Plc.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Athersys, Inc.
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 CryoLife, Inc.
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Medtronic Plc
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Organogenesis Inc.
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Zimmer Biomet Holdings, Inc.
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Lifenet Health, Inc.
11.13.1 Overview
11.13.2 Product Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 American Medical Systems Inc.
11.14.1 Overview
11.14.2 Product Overview
11.14.3 Financials
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.15 Other
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the global soft tissue repair market
Chapter 13 Appendix
LIST OF TABLES
Table 1 Soft Tissue Repair Market Synopsis, 2022–2030
Table 2 Soft Tissue Repair Market Estimates and Forecast, 2022–2030 (USD Million)
Table 3 Global Soft Tissue Repair Market, by Region, 2022–2030 (USD Million)
Table 4 Global Soft Tissue Repair Market, by Product, 2022–2030 (USD Million)
Table 5 Global Soft Tissue Repair Market, by Application, 2022–2030 (USD Million)
Table 6 Global Soft Tissue Repair Market, End User, 2022–2030 (USD Million)
Table 7 North America: Soft Tissue Repair Market, by Product, 2022–2030 (USD Million)
Table 8 North America: Soft Tissue Repair Market, by Application, 2022–2030 (USD Million)
Table 9 North America: Soft Tissue Repair Market, End User, 2022–2030 (USD Million)
Table 10 US: Soft Tissue Repair Market, by Product, 2022–2030 (USD Million)
Table 11 US: Soft Tissue Repair Market, by Application, 2022–2030 (USD Million)
Table 12 US: Soft Tissue Repair Market, End User, 2022–2030 (USD Million)
Table 13 Canada: Soft Tissue Repair Market, by Product, 2022–2030 (USD Million)
Table 14 Canada: Soft Tissue Repair Market, by Application, 2022–2030 (USD Million)
Table 15 Canada: Soft Tissue Repair Market, End User, 2022–2030 (USDMillion)
Table 16 South America: Soft Tissue Repair Market, by Product, 2022–2030 (USD Million)
Table 17 South America: Soft Tissue Repair Market, by Application, 2022–2030 (USD Million)
Table 18 South America: Soft Tissue Repair Market, End User, 2022–2030 (USDMillion)
Table 19 Europe: Soft Tissue Repair Market, by Product, 2022–2030 (USD Million)
Table 20 Europe: Soft Tissue Repair Market, by Application, 2022–2030 (USD Million)
Table 21 Europe: Soft Tissue Repair Market, End User, 2022–2030 (USD Million)
Table 22 Western Europe: Soft Tissue Repair Market, by Product, 2022–2030 (USDMillion)
Table 23 Western Europe: Soft Tissue Repair Market, by Application, 2022–2030 (USD Million)
Table 24 Western Europe: Soft Tissue Repair Market, by End User, 2022–2030(USD Million)
Table 25 Eastern Europe: Soft Tissue Repair Market, by Product, 2022–2030 (USD Million)
Table 26 Eastern Europe: Soft Tissue Repair Market, by Application, 2022–2030 (USD Million)
Table 27 Eastern Europe: Soft Tissue Repair Market, End User, 2022–2030(USD Million)
Table 28 Asia-Pacific: Soft Tissue Repair Market, by Product, 2022–2030 (USD Million)
Table 29 Asia-Pacific: Soft Tissue Repair Market, by Application, 2022–2030 (USD Million)
Table 30 Asia-Pacific: Soft Tissue Repair Market, End User, 2022–2030 (USD Million)
Table 31 Middle East & Africa: Soft Tissue Repair Market, by Product, 2022–2030 (USD Million)
Table 32 Middle East & Africa: Soft Tissue Repair Market, by Application, 2022–2030 (USD Million)
Table 33 Middle East & Africa: Soft Tissue Repair Market, End User, 2022–2030(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Soft Tissue Repair Market
Figure 3 Market Dynamics for Global Soft Tissue Repair Market
Figure 4 Soft Tissue Repair Market Share, by Product, 2022
Figure 5 Soft Tissue Repair Market Share, by Application, 2022
Figure 6 Soft Tissue Repair Market Share, End User, 2022
Figure 7 Soft Tissue Repair Market Share, by Region, 2022
Figure 8 North America: Soft Tissue Repair Market Share, by Country, 2022
Figure 9 Europe: Soft Tissue Repair Market Share, by Country, 2022
Figure 10 Asia-Pacific: Soft Tissue Repair Market Share, by Country, 2022
Figure 11 Middle East & Africa: Soft Tissue Repair Market Share, by Region, 2022
Figure 12 Soft Tissue Repair Market: Company Share Analysis, 2022 (%)
Figure 13 Stryker Corporation: Key Financials
Figure 14 Stryker Corporation: Segmental Revenue
Figure 15 Stryker Corporation: Geographical Revenue
Figure 16 C.R. Bard, Inc.: Key Financials
Figure 17 C.R. Bard, Inc.: Segmental Revenue
Figure 18 C.R. Bard, Inc.: Geographical Revenue
Figure 19 Arthrex, Inc.: Key Financials
Figure 20 Arthrex, Inc.: Segmental Revenue
Figure 21 Arthrex, Inc.: Geographical Revenue
Figure 22 Integra LifeScience Corporation: Key Financials
Figure 23 Integra LifeScience Corporation: Segmental Revenue
Figure 24 Integra LifeScience Corporation: Geographical Revenue
Figure 25 Depuy Synthes: Key Financials
Figure 26 Depuy Synthes: Segmental Revenue
Figure 27 Depuy Synthes: Geographical Revenue
Figure 28 Smith & Nephew plc: Key Financials
Figure 29 Smith & Nephew plc: Segmental Revenue
Figure 30 Smith & Nephew plc: Geographical Revenue
Figure 31 Allergan Plc.: Key Financials
Figure 32 Allergan Plc.: Segmental Revenue
Figure 33 Allergan Plc.: Geographical Revenue
Figure 34 Athersys, Inc.: Key Financials
Figure 35 Athersys, Inc.: Segmental Revenue
Figure 36 Athersys, Inc.: Geographical Revenue
Figure 37 CryoLife, Inc.: Key Financials
Figure 38 CryoLife, Inc.: Segmental Revenue
Figure 39 CryoLife, Inc.: Geographical Revenue
Figure 40 Medtronic Plc: Key Financials
Figure 41 Medtronic Plc: Segmental Revenue
Figure 42 Medtronic Plc: Geographical Revenue
Figure 43 Organogenesis Inc.: Key Financials
Figure 44 Organogenesis Inc.: Segmental Revenue
Figure 45 Organogenesis Inc.: Geographical Revenue
Figure 46 Zimmer Biomet Holdings, Inc.: Key Financials
Figure 47 Zimmer Biomet Holdings, Inc.: Segmental Revenue
Figure 48 Zimmer Biomet Holdings, Inc.: Geographical Revenue
Figure 49 Lifenet Health, Inc.: Key Financials
Figure 50 Lifenet Health, Inc.: Segmental Revenue
Figure 51 Lifenet Health, Inc.: Geographical Revenue
Figure 52 American Medical Systems Inc.: Key Financials
Figure 53 American Medical Systems Inc.: Segmental Revenue
Figure 54 American Medical Systems Inc.: Geographical Revenue